High grade neuroendocrine carcinoma of the breast, first line and maintenance immunotherapy
- PMID: 34232940
- DOI: 10.1097/CAD.0000000000001126
High grade neuroendocrine carcinoma of the breast, first line and maintenance immunotherapy
Abstract
Small cell carcinomas (SCCs) are poorly differentiated neuroendocrine tumors that arise predominantly in the lung and gastrointestinal tract (GIT). Neuroendocrine carcinomas can occur in a variety of extrapulmonary sites throughout the body, including breast, larynx, GIT, prostate, urinary bladder, ovary and cervix. This is a case report of a 55-year-old Asian female patient with metastatic high-grade neuroendocrine carcinoma of unknown origin that responded notably to off-label nivolumab maintenance treatment after first-line carboplatin - etoposide chemotherapy and radiation. After 2 years of nivolumab after platinum-based chemotherapy results from PET-CT showed no residual disease and we proceeded to mastectomy.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Adegbola T, Connolly CE, Mortimer G. Small cell neuroendocrine carcinoma of the breast: a report of three cases and review of the literature. J Clin Pathol 2005; 58:775–778.
-
- Ibrahim HB, Briggs JC, Corbishley CM. Extrapulmonary neuroendocrine carcinoma. Cancer 1984; 54:1645–1661.
-
- Grossman RA, Pedroso FE. Does surgery or radiation therapy impact survival for patients with extrapulmonary small cell cancers?. J Surg Oncol 2011; 104:604–612.
-
- López-Bonet E, Alonso-Ruano M, Barraza G, Vazquez-Martin A, Bernadó L, Menendez JA. Solid neuroendocrine breast carcinomas, incidence, clicicopathological features and immunohistochemical profiling. Oncol Rep 2008;20:1369–1374.
-
- Busolati G, Badve S. Carcinomas with neuroendocrine features. WHO classification of tumors of the breast. 2012Lyon, France: IARC Press; 62–63.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical